Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells

Cited by (910)

Items 101–200 of 910

1. Activating K-Ras mutations outwith ‘hotspot’ codons in sporadic colorectal tumours – implications for personalised cancer medicine
   Gillian C. Smith, Rebecca Bounds, Helga Wolf, Robert JC Steele, F. A. CAREY, C. Roland Wolf · 2010 · British Journal of Cancer
2. Metabolic symbiosis in cancer: Refocusing the Warburg lens
   Erica C. Nakajima, Bennett Van Houten · 2012 · Molecular Carcinogenesis
3. Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK
   Nurbubu T. Moldogazieva, Innokenty M. Mokhosoev, Alexander A. Terentiev · 2020 · Cancers
4. Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy
   Moisés Blanco, Angélica Figueroa, Enrique Grande Pulido, Rosario García Campelo, Luís Antón Aparicio · 2010 · International Journal of Endocrinology
5. RAS: Striking at the Core of the Oncogenic Circuitry
   Gimple, Ryan C., Wang, Xiuxing · 2019 · Frontiers in Oncology
6. The current understanding on the impact of KRAS on colorectal cancer
   Meng, Mingjing, Zhong, Keying, Jiang, Ting, Liu, Zhongqiu, Kwan, Hiu Yee, Su, Tao · 2021 · Biomedicine & Pharmacotherapy
7. Autophagy in cellular growth control
   Richard C. Wang, Beth Levine · 2010 · FEBS Letters
8. Warburg phenotype in renal cell carcinoma: High expression of glucose‐transporter 1 (GLUT‐1) correlates with low CD8 + T‐cell infiltration in the tumor
   Katrin Singer, Michael Kastenberger, Eva Gottfried, Christine G. Hammerschmied, Maike Büttner, Michael Aigner, Barbara Seliger, Bernhard Walter, Hans Schlößer, Arndt Hartmann et al. · 2010 · International Journal of Cancer
9. Targeting Metabolic–Redox Circuits for Cancer Therapy
   Kui Wang, Jingwen Jiang, Yunlong Lei, Shengtao Zhou, Yuquan Wei, Canhua Huang · 2019 · Trends in Biochemical Sciences
10. Myc-Driven glycolysis is a therapeutic target in glioblastoma
    Tateishi, Kensuke, Iafrate, A. John, Ho, Quan, Curry, William T., Batchelor, Tracy T., Flaherty, Keith T., Onozato, Maristela L., Lelic, Nina, Sundaram, Sudhandra, Cahill, Daniel P. et al. · 2016 · Clinical Cancer Research
11. Tumor Macroenvironment and Metabolism
    Wael Al Zoughbi, Jianfeng Huang, Ganapathy S. Paramasivan, Holger Till, Martin Pichler, Barbara Guertl‐Lackner, Gerald Höefler · 2014 · Seminars in Oncology
12. Associations Between Somatic Mutations and Metabolic Imaging Phenotypes in Non–Small Cell Lung Cancer
    Stephen S. F. Yip, John Kim, Thibaud P. Coroller, Chintan Parmar, Emmanuel Rios Velazquez, Elizabeth Huynh, Raymond H. Mak, Hugo J.W.L. Aerts · 2016 · Journal of Nuclear Medicine
13. Developing dietary interventions as therapy for cancer
    Samuel R. Taylor, John N. Falcone, Lewis C. Cantley, Marcus DaSilva Goncalves · 2022 · Nature reviews. Cancer
14. Epigenetic linkage of aging, cancer and nutrition
    Michael G. Daniel, Trygve O. Tollefsbol · 2015 · Journal of Experimental Biology
15. Gastric cancer: Metabolic and metabolomics perspectives (Review)
    Shiyu Xiao, Liya Zhou · 2017 · International Journal of Oncology
16. p58IPK-Mediated Attenuation of the Proapoptotic PERK-CHOP Pathway Allows Malignant Progression upon Low Glucose
    Anne‐Laure Huber, Justine Lebeau, Patricia Guillaumot, Virginie Pétrilli, Mouhannad Malek, Julien Chilloux, Frédérique Fauvet, Lea Francoise Payen, Alain Kfoury, Toufic Renno et al. · 2013 · Molecular Cell
17. A Form of the Metabolic Syndrome Associated with Mutations in DYRK1B
    Ali Reza Keramati, Mohsen Fathzadeh, Gwang‐woong Go, Rajvir Singh, Murim Choi, Saeed Faramarzi, Shrikant Mane, Mohammad Mehdi Kasaei, Kazem Sarajzadeh, John Hwa et al. · 2014 · New England Journal of Medicine
18. Hunger Artists: Yeast Adapted to Carbon Limitation Show Trade-Offs under Carbon Sufficiency
    Wenger, Jared W., Piotrowski, Jeffrey, Nagarajan, Saisubramanian, Chiotti, Kami, Sherlock, Gavin, Rosenzweig, Frank · 2011 · PLoS Genetics
19. GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer
    Mark Masin, Jessica Vázquez, Simona Rossi, Svenja Groeneveld, Natasha Samson, Petra Catalina Schwalie, Bart Deplancke, Laura E. Frawley, Jérôme Gouttenoire, Darius Moradpour et al. · 2014 · Cancer & Metabolism
20. The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition
    Justin Goodwin, Michael L. Neugent, Shin Yup Lee, Joshua H. Choe, Hyunsung Choi, Dana M. R. Jenkins, Robin J. Ruthenborg, Maddox W. Robinson, Ji Yun Jeong, Masaki Wake et al. · 2017 · Nature Communications
21. Autophagy-Dependent Shuttling of TBC1D5 Controls Plasma Membrane Translocation of GLUT1 and Glucose Uptake
    Srirupa Roy, Andrew M. Leidal, Jordan Ye, Sabrina M. Ronen, Jayanta Debnath · 2017 · Molecular Cell
22. Extracellular ATP is internalized by macropinocytosis and induces intracellular ATP increase and drug resistance in cancer cells
    Qian, Yanrong, Wang, Xuan, Liu, Yi, Li, Yunsheng, Colvin, Robert A., Tong, Lingying, Wu, Shiyong, Chen, Xiaozhuo · 2014 · Cancer Letters
23. Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells
    Petra Jagušt, Beatriz de Luxán‐Delgado, Beatriz Parejo-Alonso, Patricia Sancho · 2019 · Frontiers in Pharmacology
24. Cancer’s Fuel Choice: New Flavors for a Picky Eater
    Gina M. DeNicola, Lewis C. Cantley · 2015 · Molecular Cell
25. Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876
    Ma, Yibao, Wang, Wei, Idowu, Michael O., Oh, Unsong, Wang, Xiang-Yang, Temkin, Sarah M., Fang, Xianjun · 2018 · Cancers
26. Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor Growth
    Sarbajeet Nagdas, Jennifer A. Kashatus, Aldo Nascimento, Syed Saad Hussain, Riley E. Trainor, Sarah R. Pollock, Sara J. Adair, Alex D. Michaels, Hiromi Sesaki, Edward B. Stelow et al. · 2019 · Cell Reports
27. 3-bromopyruvate: Targets and outcomes
    Maria Caspar Shoshan · 2012 · Journal of Bioenergetics and Biomembranes
28. The harsh microenvironment in early breast cancer selects for a Warburg phenotype
    Mehdi Damaghi, Jeffrey West, Mark Robertson‐Tessi, Liping Xu, Meghan C. Ferrall‐Fairbanks, Paul A. Stewart, Erez Persi, Brooke L. Fridley, Philipp M. Altrock, Robert A. Gatenby et al. · 2021 · Proceedings of the National Academy of Sciences
29. Metabolic features of cancer stem cells: the emerging role of lipid metabolism
    Rita Mancini, Alessia Noto, Maria Elena Pisanu, Claudia De Vitis, Marcello Maugeri‐Saccà, Gennaro Ciliberto · 2018 · Oncogene
30. Targeting Glucose Transporters for Breast Cancer Therapy: The Effect of Natural and Synthetic Compounds
    Ana Martins Barbosa, Fátima Martel · 2020 · Cancers
31. Ketosis and the Ketogenic Diet, 2010: Advances in Treating Epilepsy and Other Disorders
    John M. Freeman, Eric Heath Kossoff · 2010 · Advances in Pediatrics
32. Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells
    Alessandra Baracca, Ferdinando Chiaradonna, Gianluca Sgarbi, Giancarlo Solaini, Lilia Alberghina, Giorgio Lenaz · 2009 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
33. Targeting metabolic reprogramming in KRAS-driven cancers
    Kenji Kawada, Kosuke Toda, Yoshiharu Sakai · 2017 · International Journal of Clinical Oncology
34. The Role of Pre-Existing Diabetes Mellitus on Hepatocellular Carcinoma Occurrence and Prognosis: A Meta-Analysis of Prospective Cohort Studies
    Wan-Shui Yang, Puthiery Va, Freddie Bray, Shan Gao, Jing Gao, Hong Lan Li, Yong-Bing Xiang · 2011 · PLoS ONE
35. Short overview on metabolomics approach to study pathophysiology of oxidative stress in cancer
    Luka Andrišić, Danuta Dudzik, Coral Barbas, Lidija Milković, Tilman Grune, Neven Žarković · 2017 · Redox Biology
36. Oncogenic KRAS and BRAF Drive Metabolic Reprogramming in Colorectal Cancer
    Josiah E. Hutton, Xiaojing Wang, Lisa J. Zimmerman, Robbert J.C. Slebos, Irina A. Trenary, Jamey D. Young, Ming Li, Daniel C. Liebler · 2016 · Molecular & Cellular Proteomics
37. Lactic Acidosis Triggers Starvation Response with Paradoxical Induction of TXNIP through MondoA
    Julia Ling-Yu Chen, Daniel Merl, Christopher W. Peterson, Jianli Wu, Patrick Yantyng Liu, Hanwei Yin, Deborah M. Muoio, Donald E. Ayer, Mike West, Jen‐Tsan Chi · 2010 · PLoS Genetics
38. Altered energy metabolism in cancer: A unique opportunity for therapeutic intervention
    Zhang, Yi, Yang, Jin-Ming · 2013 · Cancer Biology & Therapy
39. Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug
    Simone Cardaci, Enrico Desideri, Maria Rosa Ciriolo · 2012 · Journal of Bioenergetics and Biomembranes
40. IKKβ and NF-κB Transcription Govern Lymphoma Cell Survival through AKT-Induced Plasma Membrane Trafficking of GLUT1
    Thomas G. Sommermann, Kathleen E. O’Neill, David R. Plas, Ellen D. Cahir-McFarland · 2011 · Cancer Research
41. Imbalance of angiogenesis in diabetic complications: The mechanisms
    Zoya Tahergorabi, Majid Khazaei · 2012 · International Journal of Preventive Medicine
42. Colorectal Cancer and Metabolism
    Rachel E. Brown, Sarah P. Short, Christopher S. Williams · 2018 · Current Colorectal Cancer Reports
43. MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survival
    Lee, Chih-Shia, Lee, Liam C., Yuan, Tina L., Chakka, Sirisha, Fellmann, Christof, Lowe, Scott W., Caplen, Natasha J., McCormick, Frank, Luo, Ji · 2019 · Proceedings of the National Academy of Sciences
44. Functional Interaction between Responses to Lactic Acidosis and Hypoxia Regulates Genomic Transcriptional Outputs
    Xiaohu Tang, Joseph E. Lucas, Julia Ling-Yu Chen, Gregory LaMonte, Jianli Wu, Michael Changsheng Wang, Constantinos Koumenis, Jen‐Tsan Chi · 2011 · Cancer Research
45. Coupling of Glucose Deprivation with Impaired Histone H2B Monoubiquitination in Tumors
    Yasuyo Urasaki, Linda Heath, Cheng Xu · 2012 · PLoS ONE
46. The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
    Li Yu, Xun Chen, Liantang Wang, Shangwu Chen · 2016 · Oncotarget
47. The Importance of Being PI3K in the RAS Signaling Network
    Cristina Cuesta, Cristina Arévalo-Alameda, Esther Castellano · 2021 · Genes
48. Alterations of metabolic genes and metabolites in cancer
    Eric Karl Oermann, Jing Wu, Kun‐Liang Guan, Yue Xiong · 2012 · Seminars in Cell and Developmental Biology
49. The complex landscape of pancreatic cancer metabolism
    C. M. Sousa, Alec C. Kimmelman · 2014 · Carcinogenesis
50. Glucose Metabolism in Pancreatic Cancer
    Yan Liang, P. Shalem Raj, Wantong Yao, Haoqiang Ying · 2019 · Cancers
51. Arginine deiminase resistance in melanoma cells is associated with metabolic reprogramming, glucose dependence, and glutamine addiction
    Long, Yan, Tsai, Wen-Bin, Wangpaichitr, Medhi, Tsukamoto, Takashi, Savaraj, Niramol, Feun, Lynn G., Kuo, Macus Tien · 2013 · Molecular Cancer Therapeutics
52. Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy
    Sirico, Marianna, D’Angelo, Alberto, Gianni, Caterina, Casadei, Chiara, Merloni, Filippo, De Giorgi, Ugo · 2023 · Cancers
53. Mitochondrial respiratory chain super-complex I–III in physiology and pathology
    Giorgio Lenaz, Alessandra Baracca, Giovanna Barbero, Christian Bergamini, Maria Elena Dalmonte, Marianna Del Sole, Marco Faccioli, Anna Ida Falasca, Romana Fato, Maria Luisa Genova et al. · 2010 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
54. Nutrient Stress–Dysregulated Antisense lncRNA GLS-AS Impairs GLS-Mediated Metabolism and Represses Pancreatic Cancer Progression
    Shi-Jiang Deng, Hengyu Chen, Zhu Zeng, Shichang Deng, Shuai Zhu, Ye Zeng, Chi He, Mingliang Liu, Kang Huang, Jianxin Zhong et al. · 2018 · Cancer Research
55. Targeting cancer cell metabolism in pancreatic adenocarcinoma
    Romain Cohen, Cindy Neuzillet, Annemilaï Tijeras‐Raballand, Sandrine J. Faivre, Armand D.E. Gramont, Éric Raymond · 2015 · Oncotarget
56. TKTL1 Is Activated by Promoter Hypomethylation and Contributes to Head and Neck Squamous Cell Carcinoma Carcinogenesis through Increased Aerobic Glycolysis and HIF1α Stabilization
    Wenyue Sun, Yan Liu, Chad A. Glazer, Chunbo Shao, Sheetal Bhan, Semra Demokan, Ming Zhao, Michelle A. Rudek, Patrick K. Ha, Joseph A. Califano · 2010 · Clinical Cancer Research
57. Chemotherapy and signaling
    Tetyana Bagnyukova, Ilya G. Serebriiskii, Yan Zhou, Elizabeth A. Hopper-Borge, Erica A. Golemis, Igor A. Astsaturov · 2010 · Cancer Biology & Therapy
58. Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer
    Kyle Knickelbein, Lin Zhang · 2014 · Genes & Diseases
59. The glucose‐deprivation network counteracts lapatinib‐induced toxicity in resistant ErbB2‐positive breast cancer cells
    Kakajan Komurov, Jen‐Te Tseng, Melissa Muller, Elena G. Seviour, Tyler J. Moss, Lifeng Yang, Deepak Nagrath, Prahlad T. Ram · 2012 · Molecular Systems Biology
60. Lactate is an epigenetic metabolite that drives survival in model systems of glioblastoma
    Consuelo Torrini, Trang Thi Thu Nguyen, Chang Shu, Angeliki Mela, Nelson Humala, Aayushi Mahajan, E. Seeley, Guoan Zhang, Mike‐Andrew Westhoff, Georg Karpel‐Massler et al. · 2022 · Molecular Cell
61. New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells
    Eva Gottfried, Sven Arke Lang, Kathrin Renner, Anja‐Katrin Bosserhoff, Wolfram Gronwald, Michael Rehli, Sabine Einhell, Isabel Gedig, Katrin Singer, Anton Seilbeck et al. · 2013 · PLoS ONE
62. Metabostemness: A New Cancer Hallmark
    Javier Abel Menéndez, Tomás Alarcón · 2014 · Frontiers in Oncology
63. Metabolic Alterations Caused by KRAS Mutations in Colorectal Cancer Contribute to Cell Adaptation to Glutamine Depletion by Upregulation of Asparagine Synthetase
    Kosuke Toda, Kenji Kawada, Masayoshi Iwamoto, Susumu Inamoto, Takehiko Sasazuki, Senji Shirasawa, Suguru Hasegawa, Yoshiharu Sakai · 2016 · Neoplasia
64. Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer
    Lin Zhao, Yuanyuan Liu, Simiao Zhang, Lingyu Wei, Hongbing Cheng, Jinsheng Wang, Jia Wang · 2022 · Cell Death and Disease
65. How protons pave the way to aggressive cancers
    Pawel Swietach, Ebbe Boedtkjer, Stine F. Pedersen · 2023 · Nature reviews. Cancer
66. Tumor metabolism as modulator of immune response and tumor progression
    Eva Gottfried, Marina P Kreutz, Andréas Mackensen · 2012 · Seminars in Cancer Biology
67. Lactic acidosis switches cancer cells from aerobic glycolysis back to dominant oxidative phosphorylation
    Hao Wu, Minfeng Ying, Xun Hu · 2016 · Oncotarget
68. Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis
    William Ka Kei Wu, Xiaoju Wang, Alfred S.L. Cheng, Millore X.M. Luo, Simon S.M. Ng, Ka Fai To, Francis K.L. Chan, Chi Hin Cho, Joseph J.�Y. Sung, Jun Qing Yu · 2012 · Critical Reviews in Oncology/Hematology
69. Molecular Pathways: Mitochondrial Reprogramming in Tumor Progression and Therapy
    M. Cecilia Caino, Dario C. Altieri · 2015 · Clinical Cancer Research
70. The Metabolic Alterations of Cancer Cells
    Marco Sciacovelli, Edoardo Gaude, Mika Hilvo, Christian Frezza · 2014 · Methods in enzymology on CD-ROM/Methods in enzymology
71. Epigenetic mechanisms and the hallmarks of cancer: an intimate affair.
    Nadine Darwiche · 2020 · PubMed Central
72. Glucose deprivation–induced aberrant FUT1-mediated fucosylation drives cancer stemness in hepatocellular carcinoma
    Jane Ho Chun Loong, Tin Lok Wong, Man Tong, Rakesh Sharma, Lei Zhou, Kai Yu Ng, Hua-Jian Yu, Chi-Han Li, Kwan Man, Chung Mau Lo et al. · 2021 · Journal of Clinical Investigation
73. Relationship between 18F-Fluorodeoxyglucose Accumulation and KRAS / BRAF Mutations in Colorectal Cancer
    Kenji Kawada, Yuji Nakamoto, Mayumi Kawada, Koya Hida, Takuya Matsumoto, Teppei Murakami, Suguru Hasegawa, Kaori Togashi, Yoshiharu Sakai · 2012 · Clinical Cancer Research
74. Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration
    Christophe J. De Saedeleer, Paolo Ettore Porporato, Tamara Copetti, Jhudit Pérez‐Escuredo, Valéry L. Payen, Lucie Brisson, Olivier Féron, Pierre Sonveaux · 2013 · Oncogene
75. ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells
    Giulia Cesi, Geoffroy Walbrecq, Andreas David Zimmer, Stephanie Kreis, Claude Haan · 2017 · Molecular Cancer
76. Autophagy: Detection, regulation and its role in cancer and therapy response
    Pia Hönscheid, Kaustubh Datta, Michael H. Muders · 2014 · International Journal of Radiation Biology
77. Small-molecule binding of the axin RGS domain promotes β-catenin and Ras degradation
    Pu-Hyeon Cha, Yong‐Hee Cho, Sang Gyu Lee, Jaeheon Lee, Woo-Jeong Jeong, Byoung-San Moon, Ji-Hye Yun, Jee Sun Yang, Sooho Choi, Juyong Yoon et al. · 2016 · Nature Chemical Biology
78. Regulation of OGT by URI in Response to Glucose Confers c-MYC-Dependent Survival Mechanisms
    Stefan Burén, Ana L. Gomes, Ana Teijeiro, Mohamad-Ali Fawal, Mahmut Yilmaz, Krishna Seshu Tummala, Manuel Pérez‐Martínez, Manuel Rodriguez‐Justo, Ramón Campos‐Olivas, Diego Megı́as et al. · 2016 · Cancer Cell
79. Dual-specificity phosphatase 5 controls the localized inhibition, propagation, and transforming potential of ERK signaling
    Andrew M. Kidger, Linda K. Rushworth, Julia Stellzig, Jane Davidson, Chris Bryant, Cassidy Bayley, Edward Caddye, Tim Rogers, Stephen M. Keyse, Christopher James Caunt · 2017 · Proceedings of the National Academy of Sciences
80. Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK
    Jieqiong Wang, Kewen Hu, Jiawei Guo, Feixiong Cheng, Jing Lv, Wenhao Jiang, Weiqiang Lü, Jinsong Liu, Xiufeng Pang, Mingyao Liu · 2016 · Nature Communications
81. Central role of lactate and proton in cancer cell resistance to glucose deprivation and its clinical translation
    Xun Hu, Ming Chao, Hao Wu · 2017 · Signal Transduction and Targeted Therapy
82. Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced β-catenin activation
    Man‐Hsin Hung, Yao‐Li Chen, Li‐Ju Chen, Pei‐Yi Chu, Feng‐Shu Hsieh, Ming-Hsien Tsai, Chih-Ting Shih, Tzu‐I Chao, Chao‐Yuan Huang, Kuen‐Feng Chen · 2019 · Cell Death and Disease
83. CDK8 Kinase Activity Promotes Glycolysis
    Matthew D. Galbraith, Zdeněk Andrysík, Ahwan Pandey, Maria Hoh, Elizabeth A. Bonner, Amanda A. Hill, Kelly D. Sullivan, Joaquin Maximiliano Espinosa · 2017 · Cell Reports
84. Epstein-Barr Virus Immortalization of Human B-Cells Leads to Stabilization of Hypoxia-Induced Factor 1 Alpha, Congruent with the Warburg Effect
    Darekar, Suhas, Georgiou, Konstantinos, Yurchenko, Mariya, Yenamandra, Surya Pavan, Chachami, Georgia, Simos, George, Klein, George, Kashuba, Elena · 2012 · PLoS ONE
85. G6PD: A hub for metabolic reprogramming and redox signaling in cancer
    Hung‐Chi Yang, Arnold Stern, Daniel Tsun-Yee Chiu · 2020 · Biomedical Journal
86. A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities
    Franco J. Vizeacoumar, Roland R. Arnold, Frederick S. Vizeacoumar, Megha Chandrashekhar, Alla Buzina, Jordan T.F. Young, Julian Kwan, Azin Sayad, Patricia Mero, Steffen Lawo et al. · 2013 · Molecular Systems Biology
87. MEK1/2 Inhibitors AS703026 and AZD6244 May Be Potential Therapies for <i>KRAS</i> Mutated Colorectal Cancer That Is Resistant to EGFR Monoclonal Antibody Therapy
    Yoon, Juyong, Koo, Kyoung-Hwa, Choi, Kang-Yell · 2011 · Cancer Research
88. Dermatological findings in 61 mutation-positive individuals with cardiofaciocutaneous syndrome
    Dawn H. Siegel, J. McKenzie, Ilona J. Frieden, Katherine A. Rauen · 2010 · British Journal of Dermatology
89. Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
    Carlos Caicedo, María José García‐Velloso, María D. Lozano, Tania Labiano, Carmen Vigil Díaz, José María López-Picazo, Alfonso Gúrpide, Javier J. Zulueta, José Ángel Richter, José Luis Perez‐Gracia · 2014 · European Journal of Nuclear Medicine and Molecular Imaging
90. Metabolic reprograming of tumor-associated macrophages
    Abhishek Puthenveetil, Shweta Dubey · 2020 · Annals of Translational Medicine
91. Cancer-associated Isocitrate Dehydrogenase 1 (IDH1) R132H Mutation and d-2-Hydroxyglutarate Stimulate Glutamine Metabolism under Hypoxia
    Zachary J. Reitman, Christopher G. Duncan, Ethan C. Poteet, Ali Winters, Liang‐Jun Yan, David M. Gooden, Ivan Spasojević, László G. Boros, Shao-Hua Yang, Hai Yan · 2014 · Journal of Biological Chemistry
92. TAp73-induced phosphofructokinase-1 transcription promotes the Warburg effect and enhances cell proliferation
    Le Li, Lijia Li, Wěi Li, Taiqi Chen, Bin Zou, Lina Zhao, Huili Wang, Xueying Wang, Lina Xu, Xiaohui Liu et al. · 2018 · Nature Communications
93. Cerebral gluconeogenesis and diseases
    Yip, James, Geng, Xiaokun, Shen, Jiamei, Ding, Yuchuan · 2017 · Frontiers in Pharmacology
94. Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression
    Qian Lin, Na Li, Xiaochen Lu, Midie Xu, Ying Liu, Kaiyue Li, Yi Zhang, Kewen Hu, Yu-Ting Qi, Jun Yao et al. · 2023 · Nature Metabolism
95. The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4
    Celine Marques Pinheiro, Vera Miranda‐Gonçalves, Adhemar Longatto‐Filho, Anna Luiza Silva Almeida Vicente, Gustavo Nóriz Berardinelli, Cristovam Scapulatempo‐Neto, Ricardo Filipe Alves Costa, Cristiano Ribeiro Viana, Rui Manuel Reis, Fátima Baltazar et al. · 2016 · Cell Cycle
96. Glyceraldehyde-3-Phosphate Dehydrogenase: A Promising Target for Molecular Therapy in Hepatocellular Carcinoma
    Shanmugasundaram Ganapathy‐Kanniappan, Rani Kunjithapatham, Jean-François H. Geschwind · 2012 · Oncotarget
97. Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS
    Guowei Yin, Jing Huang, Johnny Petela, Hongmei Jiang, Yuetong Zhang, Siqi Gong, Jiaxin Wu, Bei Liu, Jianyou Shi, Yijun Gao · 2023 · Signal Transduction and Targeted Therapy
98. PGK1 Drives Hepatocellular Carcinoma Metastasis by Enhancing Metabolic Process
    Huijun Xie, Guihui Tong, Yupei Zhang, Shu Liang, Kairui Tang, Qinhe Yang · 2017 · International Journal of Molecular Sciences
99. Transcriptional Regulation of Energy Metabolism in Cancer Cells
    Sara Rodríguez‐Enríquez, Álvaro Marín‐Hernández, Juan Carlos Gallardo‐Pérez, Silvia Cecilia Pacheco-Velázquez, Javier Belmont-Díaz, Diana Xochiquetzal Robledo‐Cadena, Jorge Luis Vargas-Navarro, Norma Angélica Corona de la Peña, Emma Saavedra, Rafael Moreno‐Sánchez · 2019 · Cells
100. Glycometabolic rearrangements--aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications
     Lidong Cao, Jiacheng Wu, Xianzhi Qu, Jiyao Sheng, Mengying Cui, Shui Liu, Xu Huang, Yien Xiang, Bingjin Li, Xuewen Zhang et al. · 2020 · Journal of Experimental & Clinical Cancer Research